News
Home  >  News > Launch of the company Gate2Brain, based on a novel technology to transport...

Launch of the company Gate2Brain, based on a novel technology to transport drugs into the brain

From left to right, Emili Bargalló (Fundació Sant Joan de Déu), Carme Verdaguer (Bosch i Gimpera Foundation), Marc Ramis (Chasing Science), Meritxell Teixidó (Gate2Brain), and Esther Riambau (Gate2Brain), Francesc Posas (IRB Barcelona).

From left to right, Emili Bargalló (Fundació Sant Joan de Déu), Carme Verdaguer (Bosch i Gimpera Foundation), Marc Ramis (Chasing Science), Meritxell Teixidó (Gate2Brain), and Esther Riambau (Gate2Brain), Francesc Posas (IRB Barcelona).

09/07/2020

Recerca

Researchers from IRB Barcelona, the University of Barcelona (UB) and Sant Joan de Déu Research Institute – Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel technology developed at IRB Barcelona to transport drugs into the brain. Gate2Brain is the second joint spin-off by IRB Barcelona and the UB to be funded by the Mind the Gap Programme, from the Botín Foundation.

Further information

Share this at:
| More |
  • Follow us:
  • Button to access University of Barcelona's Facebook profile
  • Button to access University of Barcelona's Twitter profile
  • Button to access University of Barcelona's Instagram profile
  • Button to access University of Barcelona's Linkedin profile
  • Button to access University of Barcelona's Youtube profile
  • Button to access University of Barcelona's Google+ profile
  • ??? peu.flickr.alt ???
Member of International recognition of excellence HR Excellence in Research logo del leru - League of European Research Universities logo del bkc - campus excel·lència logo del health universitat de barcelona campus

© Universitat de Barcelona